RUXTA

This brand name is authorized in Nigeria.

Active ingredients

The drug RUXTA contains one active pharmaceutical ingredient (API):

1	Febuxostat UNII 101V0R1N2E - FEBUXOSTAT
	Uric acid is the end product of purine metabolism in humans and is generated in the cascade of hypoxanthine → xanthine → uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO.
	Read more about Febuxostat

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9650	Tablet	Ruxta 80 Tablets TAB 80 mg 3 x 10's (in Alu-Alu blisters)	Tablet RUXTA 80 TABLETS FEBUXOSTAT 80MG Active: FEBUXOSTAT 80MG. Excipients: Lactose Monohydrate Microcrystalline Cellulose Croscarmellose Sodium Sodium Lauryl Sulphate Purified Water Hydroxypropyl cellulose Colloidal Anhydrous Silica Magnesium Stearate Instacoat universal Yellow (A05D10519) B4-9650 Drugs MUSCULO-SKELETAL SYSTEM Imported Products 3X10 POM 1 28/02/2024 MICRO NOVA PHARMACEUTICALS IND LTD, 16,AJASASTREET,AJAOROADOFFADENIYIJONES,IKEJA,LAGOS,LAGOS 81299901 solomonsemicrolabs@gmail.com M/S MICRO LABS LIMITED., 92, SIPCOT IND. COMPLEX HOSUR 635126 INDIA, India	30/01/2025
B4-9853	Tablet	Ruxta 40 Tablets TAB 40 mg 3 x 10's (in Alu blisters)	Film Coated Tablet Ruxta 40 Tablets "ACTIVE: FEBUXOSTAT TABLETS 40 MG. EXCIPIENTS: LACTOSE MONOHYDRATE MICROCRYSTALLINE CELLULOSE CROSCARMELLOSE SODIUM SODIUM LAURYL SULPHATE PURIFIED WATER HYDROXYPROPYL CELLULOSE COLLOIDAL ANHYDROUS SILICA MAGNESIUM STEARATE INSTACOAT UNIVERSAL BROWN (ICU 6698) " B4-9853 Drugs Imported Product 3x10 20-03-2024 MICRO NOVA PHARMACEUTICALS IND LTD, Plot 3, Billings Way, Oregun 081299901 solomonsemicrolabs@gmail.com Micro Labs Limited, 92, SIPCOT HOSUR-635-126,INDIA	27/03/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M04AA03	Febuxostat	M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production
Discover more medicines within M04AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9650, B4-9853